Roberto Ferri
Keine laufenden Positionen mehr
Profil
Mr. Roberto Ferri is Independent Director at Sorin SpA.
He is on the Board of Directors at Sorin SpA.
Mr. Ferri was previously employed as Chairman & Managing Director by GlaxoSmithKline SpA.
He received his undergraduate degree from the University of Bologna.
Ehemalige bekannte Positionen von Roberto Ferri
| Unternehmen | Position | Ende |
|---|---|---|
GlaxoSmithKline SpA
 GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy. | Vorsitzender | 01.01.2005 |
| SORIN SPA | Direktor/Vorstandsmitglied | - |
Ausbildung von Roberto Ferri
| Alma Mater Studiorum - Università di Bologna | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
GlaxoSmithKline SpA
GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy. | Health Technology |
Sorin SpA
 Sorin SpA Medical SpecialtiesHealth Technology Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy. | Health Technology |
